Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ZenaTech’s ZenaDrone Subsidiary Applies for Green UAS Certification for IQ Square Drone to Sell to US Defense and Government
-
Brixton Metals Drills 1.5m of 9.5 g/t Gold, 13.8% Copper, 771.5 g/t Silver, 7.6% Lead, 609 g/t Tellurium, 7.1% Zinc, and >1% Antimony
-
Reunion Neuroscience Announces Publication of RE104 Phase 1 Data in The Journal of Clinical Psychopharmacology
-
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
-
BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET
-
trivago N.V.'s Second Quarter 2025 Earnings Release Scheduled for August 5, 2025; Webcast Scheduled for August 6, 2025
-
trivago N.V.'s Second Quarter 2025 Earnings Release Scheduled for August 5, 2025; Webcast Scheduled for August 6, 2025
-
Form 8.3 - [MARLOWE PLC - 21 07 2025] - (CGWL)
-
O-I GLASS VALIDATES EARLY ACHIEVEMENT OF KEY SUSTAINABILITY GOALS, SETS SIGHTS ON PARIS-ALIGNED TARGETS
-
Draganfly Secures Strategic Military Order for Commander 3XL UAV Systems
-
O-I GLASS VALIDATES EARLY ACHIEVEMENT OF KEY SUSTAINABILITY GOALS, SETS SIGHTS ON PARIS-ALIGNED TARGETS
-
DTC Appoints John Payne to Lead Wave Central’s Next Phase of Growth in Wireless Broadcast
-
CMMB Introduces Derek Yach as New Global Health Advisor
-
Manhattan Bridge Capital, Inc. Reports Second Quarter Results for 2025
-
uniQure to Announce Second Quarter 2025 Financial Results
-
Gilat Awarded Approximately $60 Million to Provide Digital Inclusion Solutions in Peru
-
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
-
USA Rare Earth Announces Date for Second Quarter 2025 Results and Conference Call
-
ProMIS Neurosciences Announces Private Placement Financing
-
Old National Bancorp Reports Second Quarter 2025 Results and Names New President and COO
-
Fury Reports Encouraging Metallurgical Test Results from the Ninaaskumuwin Lithium Discovery at Elmer East
-
Health Canada Authorizes bioLytical’s iStatis Syphilis Test, Boosting Rapid Response to Rising Infections in Canada
-
Capital City Bank Group, Inc. Reports Second Quarter 2025 Results
-
Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation
-
S8 Global Fintech & Regtech Fund (Luxembourg), Strategic Fintech Investor, Reports More Than 10% Ownership Position in RYVYL
-
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
-
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
-
CGS Announces Corporate Restructuring; Forms Four Independent Companies to Accelerate Growth
-
Gaming and Leisure Properties, Inc. Names Carlo Santarelli Senior Vice President, Corporate Strategy and Investor Relations
-
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
-
SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices
-
Seres Therapeutics Announces Leadership Transition
-
OncoC4 Doses First Patient with Potential Best-in-Class PD-1/VEGF Bispecific Antibody AI-081 in Phase 2 Portion of BIPAVE-001 Trial for Advanced Solid Tumors in US
-
HydroGraph Confirms No Undisclosed Material Information or Change in Operations
-
ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules
-
Quantum BioPharma Makes Strategic Investment in GameStop Corp.
-
Ready Capital Secures Ownership of The Ritz-Carlton Portland Project
-
S8 Global Fintech & Regtech Fund (Luxembourg), Strategic Fintech Investor, Reports More Than 10% Ownership Position in RYVYL
-
Enthusiast Gaming’s U.GG Launches Support for Rematch, Surpasses 100,000 Player Profiles in First Two Weeks
-
Interpublic Announces Second Quarter and First Half 2025 Results
-
Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
-
Bitfarms Announces Corporate Share Buyback Program
-
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
-
Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer
-
Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors
-
GURU Organic Energy Announces Renewal of Its Normal Course Issuer Bid
-
ChargeScape and PSEG Long Island Partner to Enroll BMW and Ford Electric Vehicles in First-Ever Grid Reliability Program Participation
-
CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Q2-2025
-
Avalyn Completes Oversubscribed $100 Million Series D Financing to Further Advance Clinical Development of Novel Inhaled Therapies for Pulmonary Fibrosis
-
InspireMD to Announce Second Quarter 2025 Financial Results
